Clostridium difficile vaccine 2904545A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Clostridium difficile vaccine 2904545A, covering 2024-09-23 to 2024-09-23. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years [Phase 1]